Prostate cancer is a medical condition with active clinical research programs worldwide.

10 total trials for this combination

Trials

NCT ID	Title	Status	Phase
NCT01546987	Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer	COMPLETED	PHASE3
NCT00331773	Radiation Therapy in Treating Patients With Stage II Prostate Cancer	COMPLETED	PHASE3
NCT00567580	Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer	ACTIVE_NOT_RECRUITING	PHASE3
NCT00288080	Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer	COMPLETED	PHASE3
NCT00936390	Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer	COMPLETED	PHASE3
NCT01368588	Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer	ACTIVE_NOT_RECRUITING	PHASE3
NCT00134056	S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy	COMPLETED	PHASE3
NCT00931528	Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy	COMPLETED	PHASE3
NCT03809000	A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery	ACTIVE_NOT_RECRUITING	PHASE2
NCT00079001	Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases	COMPLETED	PHASE3

Related Pages

All Prostate cancer trials All trials in Exeter, United States